ABBOTT LABORATORIES
8-K, 2001-01-18
PHARMACEUTICAL PREPARATIONS
Previous: EQUITY FOCUS TRUSTS S T A R T 2001 SERIES, 487, EX-99.5.1, 2001-01-17
Next: ABBOTT LABORATORIES, 8-K, EX-99.1, 2001-01-18


QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

January 16, 2001
Date of Report (Date of earliest event reported)

ABBOTT LABORATORIES
(Exact name of registrant as specified in its charter)


Illinois 1-2189 36-0698440
(State or other (Commission File Number) (I.R.S. Employer
Jurisdiction of Incorporation)   Identification No.)

100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (847) 937-6100




Item 5.  Other Events

    Attached as Exhibit 99.1 and incorporated herein by this reference is a press release announcing Abbott's sales and earnings for the fourth-quarter and year 2000.

Item 7.  Financial Statements and Exhibits.

    (c) Exhibits.

Exhibit No.
  Exhibit

99.1   Press Release, dated January 16, 2001


SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

    ABBOTT LABORATORIES

 

 

By:

 

/s/ 
GARY P. COUGHLAN   
       
Gary P. Coughlan
Senior Vice President, Finance
and Chief Financial Officer

Date: January 18, 2001




QuickLinks

SIGNATURE


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission